New Faculty - September 2019
A warm welcome to new Department of Medicine faculty members who started in September!
Internal Medicine Residency News, Sept. 23, 2019
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for Sept. 23, 2019.
DGIM faculty members in the VA – 3 steps to reach Duke online resources
New to Duke? But, you work across the street in the Durham VA? We believe there are online Duke resources you may be missing.
Rodger Liddle Has A Gut Feeling About the Origins of Parkinson's Disease
What is a gastroenterologist doing studying Parkinson’s Disease?
This is a question that Rodger Liddle, MD, a professor in the Department of Medicine in the School of Medicine, gets a lot. The answer involves a superhighway, a conversation with a Nobel Laureate, and a plastic foot.
Hemming, Bowlby, + team selected for Duke AHEAD funding
At this week's Duke AHEAD Education day, GIM faculty members, Drs. Patrick Hemming and
Julia Gamble named Practice Nurse of the Year by NCNA
Julia Gamble, NP, an Advance Practice Provider at the Duke Outpatient Clinic was named Practice Nurse of the Year by the North Carolina Nurses Association (NCNA).
2019 Flu Vaccinations
It's that time of year again to get your flu vaccination. Employees required to be vaccinated must be compliant by by 10 a.m. on Nov. 5, 2019.
Internal Medicine Residency News, Sept. 16, 2019
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for Sept. 16, 2019.
Seeking candidates for Chief, Division of Hematologic Malignancies & Cellular Therapy
The Department of Medicine and the Duke Cancer Institute at Duke Health in Durham, North Carolina, are seeking candidates for Chief of the Division of Hematologic Malignancies & Cellular Therapy.
Leadership update for Division of Hematologic Malignancies and Cellular Therapy
Nelson Chao, MD, MBA, has served as the chief for the Division of Cellular Therapy since 1996, and for the expanded Division of Hematologic Malignancies & Cellular Therapy since 2013. At the same time, Dr. Chao also has served as leader of the Hematologic Malignancies & Cellular Therapy Research Program for the Duke Cancer Institute (DCI).